<p><b>Note:</b></p>a<p>The log-rank <i>p</i> value was derived from the Kaplan–Meier method using the log-rank test;</p>b<p>the <i>p</i> value was derived from the Cox regression model; HR, hazard ratio; CI, confidence interval;</p><p>*L, the group with low <i>MHC</i> gene expression pattern; H, the group with high <i>MHC</i> gene expression pattern.</p
Some early stage NSCLC patients have a better survival prospects than others. In any event, the long...
<p>Results of multivariate Cox regression analysis on NSCLC patients’ survival.</p
<p>Survival curves from the time of diagnosis for NSCLC patients with either high (+) or low (−) exp...
<p><b>Note:</b></p>a<p>The log-rank <i>p</i> value was derived from the Kaplan–Meier method using th...
<p>Note:</p>a<p>The log-rank <i>p</i> value was derived from the Kaplan-Meier method using the log-r...
<p>Shown are survival curves for groups of NSCLC patients with the lowest and highest tumor expressi...
<p>Patients were generally classified into two groups (short-term versus long-term sur...
<p>(A) Stratified according to Twist expression (log-rank test, <i>P</i><0.01). (B) Stratified accor...
<p>(A) Heat map of the <i>MHC</i> genes in the NSCLC patients. For the tissue expression dataset for...
*<p>2 year survival for high (H) and low (L) gene expression respectively significant differences an...
<div><p>(A) Kaplan-Meier survival curves for patients with stage IA and with IB NSCLC.</p> ...
<p>Univariate analysis of OS (A) and DFS (B) with a Cox proportional hazards model in lung carcinoma...
<p>Influence of clinical stage and gene expression on overall survival in 60 patients with NSCLC (mu...
<p>0, normal expression; 1, one overexpression; 2 co-overexpression of two markers.</p>*<p><i>P</i><...
<p>Metabolic co-expression variables in cancer and stromal cells as predictors of disease-specific s...
Some early stage NSCLC patients have a better survival prospects than others. In any event, the long...
<p>Results of multivariate Cox regression analysis on NSCLC patients’ survival.</p
<p>Survival curves from the time of diagnosis for NSCLC patients with either high (+) or low (−) exp...
<p><b>Note:</b></p>a<p>The log-rank <i>p</i> value was derived from the Kaplan–Meier method using th...
<p>Note:</p>a<p>The log-rank <i>p</i> value was derived from the Kaplan-Meier method using the log-r...
<p>Shown are survival curves for groups of NSCLC patients with the lowest and highest tumor expressi...
<p>Patients were generally classified into two groups (short-term versus long-term sur...
<p>(A) Stratified according to Twist expression (log-rank test, <i>P</i><0.01). (B) Stratified accor...
<p>(A) Heat map of the <i>MHC</i> genes in the NSCLC patients. For the tissue expression dataset for...
*<p>2 year survival for high (H) and low (L) gene expression respectively significant differences an...
<div><p>(A) Kaplan-Meier survival curves for patients with stage IA and with IB NSCLC.</p> ...
<p>Univariate analysis of OS (A) and DFS (B) with a Cox proportional hazards model in lung carcinoma...
<p>Influence of clinical stage and gene expression on overall survival in 60 patients with NSCLC (mu...
<p>0, normal expression; 1, one overexpression; 2 co-overexpression of two markers.</p>*<p><i>P</i><...
<p>Metabolic co-expression variables in cancer and stromal cells as predictors of disease-specific s...
Some early stage NSCLC patients have a better survival prospects than others. In any event, the long...
<p>Results of multivariate Cox regression analysis on NSCLC patients’ survival.</p
<p>Survival curves from the time of diagnosis for NSCLC patients with either high (+) or low (−) exp...